PRESS RELEASE published on 11/25/2025 at 18:30, 11 months 17 days ago EQS-Adhoc: LR HEALTH & BEAUTY SE RECEIVES SUPPORTING VOTING INTENTIONS BY 69.57% OF THE ADJUSTED NOMINAL AMOUNT FOR TEMPORARY WAIVERS UNDER THE 2024/2028 BONDS LR Health & Beauty SE has received support from bondholders representing 69.57% of adjusted nominal amount for temporary waivers under the 2024/2028 bonds Bondholders LR Health & Beauty SE 2024/2028 Bonds Temporary Waivers Voting Intentions
BRIEF published on 11/14/2025 at 15:51, 11 months 28 days ago LR Health & Beauty SE Seeks Bondholder Approval on Covenant Breach LR Health & Beauty Voting Deadline Covenant Breach Bond Procedure 2024/2028 Bonds
BRIEF published on 11/14/2025 at 15:51, 11 months 28 days ago LR Health & Beauty SE sollicite l'approbation des obligataires suite à une violation de ses engagements. Date Limite De Vote Procédure De Cautionnement Violation De L'engagement LR Santé Et Beauté Obligations 2024/2028
PRESS RELEASE published on 11/14/2025 at 15:46, 11 months 28 days ago LR Health & Beauty SE initiates a Written Procedure under its outstanding 2024/2028 Bonds LR Health & Beauty SE initiates a Written Procedure among Bondholders to address an expected covenant breach regarding net debt to EBITDA ratio of 2024/2028 Bonds Bondholders Financial LR Health & Beauty Written Procedure Leverage Covenant
BRIEF published on 10/24/2025 at 18:55, 1 year ago LR Health & Beauty SE Reports Q3 2025 Business Development EBITDA Forecast Sales Decline LR Health & Beauty Q3 2025 Results Fragrance Portfolio
BRIEF published on 10/24/2025 at 18:55, 1 year ago LR Health & Beauty SE publie son développement commercial au troisième trimestre 2025 Baisse Des Ventes Prévisions D'EBITDA LR Santé & Beauté Résultats Du Troisième Trimestre 2025 Portefeuille De Parfums
PRESS RELEASE published on 10/24/2025 at 18:50, 1 year ago LR Health & Beauty SE reports on business development in the third quarter of 2025 LR Health & Beauty SE reports on business development in Q3 2025, with sales of EUR 66.0 million and EBITDA of EUR 2.9 million. Focus on fragrance segment, capital structure, and earnings guidance revision Sales EBITDA Business Development Fragrance LR Health & Beauty SE
BRIEF published on 10/20/2025 at 20:22, 1 year ago LR Health & Beauty SE Faces Financial Challenges Amid Leverage Covenant Breach Financial Restructuring LR Health & Beauty Interest Payment Deferral Bondholder Negotiations Leverage Covenant Breach
BRIEF published on 10/20/2025 at 20:22, 1 year ago LR Health & Beauty SE confrontée à des difficultés financières suite à une violation de la clause d'endettement Restructuration Financière LR Santé & Beauté Report Du Paiement Des Intérêts Négociations Avec Les Obligataires Violation De L'alliance De Levier
PRESS RELEASE published on 10/20/2025 at 20:17, 1 year ago EQS-Adhoc: LR Health & Beauty SE: BREACH OF LEVERAGE COVENANT / NO INTEREST PAYMENT / STANDSTILL NEGOTIATIONS WITH AN AD HOC GROUP OF BONDHOLDERS / APPOINTMENT OF A REPUTABLE FIRM TO SUPPORT ... LR Health & Beauty SE announces breach of leverage covenant, no interest payment, and standstill negotiations with bondholders. Firm appointed to support financial restructuring Bondholders LR Health & Beauty SE Financial Restructuring Leverage Covenant Standstill Negotiations
Published on 11/13/2026 at 02:40, 5 hours 47 minutes ago Jaguar Mining Reports Third Quarter 2026 Results with 67% Growth in Adjusted Net Income and 46% Higher Adjusted EBITDA
Published on 11/13/2026 at 02:10, 6 hours 17 minutes ago Amarc to Participate in Consolidation of Aurora West Through Aurora Minerals LTD
Published on 11/12/2026 at 23:25, 9 hours 2 minutes ago Renegade Gold Announces Bought Deal Private Placement for Gross Proceeds of C$5 Million
Published on 11/12/2026 at 23:05, 9 hours 22 minutes ago Caldwell Reports Fourth Quarter and Full Year Fiscal 2026 Results; Increases Quarterly Dividend and Declares a Special Dividend
Published on 11/12/2026 at 23:00, 9 hours 27 minutes ago Redwood AI Announces Chemical Risk Analysis Update to its AI-Powered Reactosphere Platform to Support Faster Reaction Safety Screening
Published on 11/13/2026 at 08:00, 26 minutes ago Uzin Utz SE has published its third-quarter financial results: an increase in sales and stable earnings performance despite subdued momentum in the construction sector due to ongoing market headwinds
Published on 11/13/2026 at 07:48, 38 minutes ago Nagarro releases unaudited Q3 2026 results, posts 2.7% constant currency growth for 9 months ended September 2026
Published on 11/13/2026 at 07:30, 56 minutes ago Mutares seeks early refinancing of the outstanding Bond 2023/2027 by increasing the Bond 2024/2029 by up to EUR 165 million
Published on 11/13/2026 at 07:29, 57 minutes ago Bechtle delivers double-digit growth in business volume and EBT, raises 2026 forecast again
Published on 11/13/2026 at 08:00, 27 minutes ago Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 9 hours 14 minutes ago Belgrano continues the implementation of its public share buyback offer (OPRA)
Published on 11/12/2026 at 23:12, 9 hours 14 minutes ago Belgrano poursuit la mise en oeuvre de son projet d'OPRA
Published on 11/12/2026 at 23:00, 9 hours 27 minutes ago Assemblée générale du 12 novembre 2026 : quorum non atteint - Convocation d’une seconde assemblée générale le 27 novembre 2026
Published on 11/12/2026 at 18:36, 13 hours 50 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2026